About US
Contact us
-
2012’PhexTour pharmaceutical excipients application technology national tour seminar (Haikou station, Shenzhen station) has come to an endtechnology seminar on the national tour (Haikou station, Shenzhen station) has come to an end2012 PhexTour pharmaceutical excipients application technology national tour seminar first station-Haikou , on March 20th, in Haikou sun city hotel has come to an end. 35 local pharmaceutical companie2012/3/30
-
SFDA requires further strengthening food safety of catering chain enterprisesIn order to further strengthen the food safety supervision over catering chain enterprises, standardize the operation of catering chain enterprises, promote legitimate and honest operation, and ensure2012/3/30
-
Pfizer open to Abbott-style split, analyst saysIs Pfizer pursuing a full-scale breakup strategy, just on the down low and on the long finger? Goldman Sachs analyst Jami Rubin has set investors abuzz by suggesting that the drugmaker won't stop with2012/3/29
-
Judge slams FDA for importing lethal-injection drugsA U.S. judge sided with death row inmates who sued the FDA for importing a drug used in lethal injections. The prisoners had claimed that theagency's decision to allow foreign versions of sodium thiop2012/3/29
-
U.S. questions India's IP regime after Nexavar moveIs intellectual property safe in India? That's the question drugmakers--and now U.S. officials--are asking, as the country's top court considers a landmark patent case, and after the government ordere2012/3/28
-
Arkansas jury hears state's claims against J&JAs a trial over Johnson & Johnson's ($JNJ) Risperdal marketing opens in Arkansas, the state's lawyers contend that company officials misled doctors about the atypical antipsychotic, defrauding Med2012/3/28
-
Roche to offer cancer drugs in India at deep discountsJust days after officials in India stripped Bayer ($BAY) of its exclusive rights to Nexavar, giving a local company the right to produce it at a deep discount, Roche ($RHHBY) has stepped up with plans2012/3/27
-
SFDA Commissioner Yin Li and Deputy Commissioner Bian Zhenjia meet with European Commissioner for Health and Consumer Policy and Director General of European Commission DG Health and ConsumersOn March 20, 2012, Yin Li, Commissioner of the State Food and Drug Administration (SFDA) and SFDA Deputy Commissioner Bian Zhenjia met with the visiting John Dalli, European Commissioner for Health an2012/3/27
-
FDA seeks advice on making more drugs OTCThere is more talk in Washington, D.C., about stretching the definition of over-the-counter. The FDA is holding its second day of hearings on whether some prescription medications should be sold OTC2012/3/26
-
SFDA issues Requirements on the Naming of Health Food and Guide to the Naming of Health FoodIn order to ensure scientific and standard naming of health foods and protect the legitimate rights and interests of consumers, the State Food and Drug Administration (SFDA) revised the Requirements o2012/3/26